iBio
IBIO
#9815
Rank
A$67.95 M
Marketcap
A$3.02
Share price
-2.33%
Change (1 day)
-40.68%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): A-$2.39

According to iBio's latest financial reports the company's current EPS (TTM) is A-$2.22. an increase over its 2024 EPS that were of A-$9.35.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025A-$2.52-73.08%
2024A-$9.35-93.88%
2023A-$152.81-8.14%
2022A-$166.3592.67%
2021A-$86.34-80.33%
2020A-$438.90-35.11%
2019A-$676.33-38.96%
2018A-$1,108-6.1%
2017A-$1,18036.67%
2016A-$863.4033.33%
2015A-$647.5550%
2014A-$431.70-53.85%
2013A-$935.35-7.14%
2012A-$1,007-64.1%
2011A-$2,80677.27%
2010A-$1,583144.44%
2009A-$647.5512.93%
2008A-$573.4212.2%
2007A-$511.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.02-777.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A-$0.75-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$11.47 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.03-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA